<code id='2F7C997054'></code><style id='2F7C997054'></style>
    • <acronym id='2F7C997054'></acronym>
      <center id='2F7C997054'><center id='2F7C997054'><tfoot id='2F7C997054'></tfoot></center><abbr id='2F7C997054'><dir id='2F7C997054'><tfoot id='2F7C997054'></tfoot><noframes id='2F7C997054'>

    • <optgroup id='2F7C997054'><strike id='2F7C997054'><sup id='2F7C997054'></sup></strike><code id='2F7C997054'></code></optgroup>
        1. <b id='2F7C997054'><label id='2F7C997054'><select id='2F7C997054'><dt id='2F7C997054'><span id='2F7C997054'></span></dt></select></label></b><u id='2F7C997054'></u>
          <i id='2F7C997054'><strike id='2F7C997054'><tt id='2F7C997054'><pre id='2F7C997054'></pre></tt></strike></i>

          entertainment

          entertainment

          author:Wikipedia    Page View:566
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          Setback for rare diseases as Taysha Gene Therapies pulls back
          Setback for rare diseases as Taysha Gene Therapies pulls back

          AdobeIn2020,asbiotechstockssurgedamidthepandemic,astartupcalledTayshaGeneTherapiesraisedover$300mill

          read more
          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more

          CDC picks Alphabet's Verily for wasterwater surveillance contract

          AdobeAlphabet’slifesciencescompanyVerilyhasscoreditsfirstCentersforDiseaseControlandPreventioncontra